Salvatore De Rosa

Author PubWeight™ 35.48‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Circulating microRNAs in patients with coronary artery disease. Circ Res 2010 6.28
2 Administration of a loading dose has no additive effect on platelet aggregation during the switch from ongoing clopidogrel treatment to ticagrelor in patients with acute coronary syndrome. Circ Cardiovasc Interv 2014 1.97
3 C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation. Cardiovasc Res 2005 1.67
4 Insulation defects of thin high-voltage ICD leads: an underestimated problem? J Cardiovasc Electrophysiol 2011 1.19
5 Aspiration thrombectomy: an easily forgiven "latecomer". J Am Coll Cardiol 2014 1.09
6 Intracoronary versus intravenous abciximab bolus administration. J Am Coll Cardiol 2014 1.08
7 Cyclic peptides from a Ruegeria strain of bacteria associated with the sponge Suberites domuncula. J Nat Prod 2004 0.96
8 Risk for permanent pacemaker after transcatheter aortic valve implantation: a comprehensive analysis of the literature. J Cardiovasc Electrophysiol 2011 0.91
9 The STS score is the strongest predictor of long-term survival following transcatheter aortic valve implantation, whereas access route (transapical versus transfemoral) has no predictive value beyond the periprocedural phase. Interact Cardiovasc Thorac Surg 2013 0.89
10 Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation. Circulation 2004 0.88
11 Exocellular peptides from Antarctic psychrophile Pseudoalteromonas Haloplanktis. Mar Biotechnol (NY) 2005 0.87
12 A novel cyclopeptide from a bacterium associated with the marine sponge Ircinia muscarum. Z Naturforsch C 2003 0.86
13 Tissue factor is induced by resistin in human coronary artery endothelial cells by the NF-ĸB-dependent pathway. J Vasc Res 2010 0.85
14 Avarol inhibits TNF-alpha generation and NF-kappaB activation in human cells and in animal models. Life Sci 2007 0.85
15 Different vascular response to concurrent implantation of sirolimus- and zotarolimus-eluting stents in the same vessel. Heart Vessels 2009 0.84
16 Exocellular cyclic dipeptides from a Ruegeria strain associated with cell cultures of Suberites domuncula. Mar Biotechnol (NY) 2003 0.84
17 Prognostic impact of using drug-eluting-stents on outcome and strategy in multivessel PCI: data from the Frankfurt MV-PCI registry. J Cardiol 2012 0.83
18 Tomato derived polysaccharides for biotechnological applications: chemical and biological approaches. Molecules 2008 0.81
19 Diketopiperazines produced by the halophilic archaeon, Haloterrigena hispanica, activate AHL bioreporters. Microb Ecol 2011 0.81
20 HMG-CoA reductase inhibitors reduce nicotine-induced expression of cellular adhesion molecules in cultured human coronary endothelial cells. J Vasc Res 2007 0.81
21 Pro-atherothrombotic effects of leptin in human coronary endothelial cells. Thromb Haemost 2010 0.81
22 Influence of observer experience and training on proficiency in coronary CT angiography interpretation. Eur J Radiol 2013 0.81
23 Cacospongionolide B suppresses the expression of inflammatory enzymes and tumour necrosis factor-alpha by inhibiting nuclear factor-kappa B activation. Br J Pharmacol 2003 0.80
24 Experimental formulation of a kinetic model describing the nitrification process in biological aerated filters filled with plastic elements. Environ Technol 2014 0.79
25 The role of neopterin in cardiovascular disease. Monaldi Arch Chest Dis 2007 0.79
26 Potential antipsoriatic avarol derivatives as antioxidants and inhibitors of PGE(2) generation and proliferation in the HaCaT cell line. J Nat Prod 2004 0.78
27 Identification of avarol derivatives as potential antipsoriatic drugs using an in vitro model for keratinocyte growth and differentiation. Life Sci 2006 0.78
28 Cacospongionolide and scalaradial, two marine sesterterpenoids as potent apoptosis-inducing factors in human carcinoma cell lines. PLoS One 2012 0.78
29 Cyclic dipeptides produced by marine sponge-associated bacteria as quorum sensing signals. Nat Prod Commun 2014 0.78
30 Inhibition of the tissue factor coagulation pathway. Curr Vasc Pharmacol 2004 0.77
31 Synthesis and evaluation of diverse thio avarol derivatives as potential UVB photoprotective candidates. Bioorg Med Chem Lett 2007 0.77
32 Delayed sudden radial artery rupture after left transradial coronary catheterization: a case report. Medicine (Baltimore) 2015 0.77
33 MicroRNAs as biomarkers in pituitary tumors. Neurosurgery 2014 0.77
34 Standardization and normative data obtained in the Italian population for a new verbal fluency instrument, the phonemic/semantic alternate fluency test. Neurol Sci 2013 0.76
35 Vascular miRNAs after balloon angioplasty. Trends Cardiovasc Med 2013 0.75
36 Activated platelets stimulate tissue factor expression in smooth muscle cells. Thromb Res 2003 0.75
37 Clinical and Procedural Outcomes of 5-French versus 6-French Sheaths in Transradial Coronary Interventions. Medicine (Baltimore) 2015 0.75
38 Toxicity and biodegradation of the LAS surfactant 1-(p-sulfophenyl)nonane in presence of the ascidian Styela plicata. Chemosphere 2008 0.75
39 Further in vitro evaluation of cytotoxicity of the marine natural product derivative 4'-leucine-avarone. Nat Prod Res 2014 0.75
40 Bioactive exopolysaccharides from the cultured cells of tomato, Lycopersicon esculentum var. San Marzano. J Nat Prod 2006 0.75
41 Further in vitro evaluation of antimicrobial activity of the marine sesquiterpene hydroquinone avarol. Curr Pharm Biotechnol 2014 0.75
42 Mini mental Parkinson test: standardization and normative data on an Italian sample. Neurol Sci 2013 0.75
43 Sugar composition of the moss Rhodobryum ontariense (Kindb.) Kindb. Nat Prod Res 2011 0.75
44 A new depsidone of Lobaria pulmonaria with acetylcholinesterase inhibition activity. J Enzyme Inhib Med Chem 2012 0.75
45 Computational analysis of stenosis geometry effects on right coronary hemodynamics. Conf Proc IEEE Eng Med Biol Soc 2015 0.75
46 Synthesis and biological activities of thio-avarol derivatives. J Nat Prod 2008 0.75
47 Further in vitro biological activity evaluation of amino-, thio- and ester-derivatives of avarol. J Enzyme Inhib Med Chem 2014 0.75
48 Impact of interventional strategy for unprotected left main coronary artery percutaneous coronary intervention on long-term survival. Can J Cardiol 2012 0.75